About Emergent Bioservices
We are the Bioservices (Contract Development & Manufacturing) division of Emergent BioSolutions (NYSE: EBS). With 25 years of experience developing, manufacturing, and delivering our own portfolio of therapeutic and vaccine products, we offer biopharma companies a strategic and reliable manufacturing solution for their clinical and commercial products.
We have the scientific and regulatory compliance experience, development and manufacturing resources, and efficient technology transfer capabilities that can harness the urgency, acuity, and scalability required to bring life-saving, life-extending products to market.